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IMMUNOBIOLOGY AND GENOMICS 
The Difficulty of Eliminating Donor Leukocyte 
Microchimerism in Rat Recipients Bearing Established 
Organ Allografts 
Tetsuma Kiyom 0 to, 1,2 Hideyoshi Toyokawa, 1,2 Atsunori Nakao,1,2 Takashi Kaizu, 1,2 Anthony J. Demetris, 1,3 
Thomas E. Starzi, 1,2 and Noriko Murase1,2,4 
Background. Unequivocal eradication of donor leukocyte microchimerism from recipients of long-surviving organ 
transplants has never been reported. Here we describe a drastic attempt to accomplish this objective. 
Methods. In control experiments, a rank order of microchimerism and of associated donor specific nonreactivity was 
produced in Brown-Norway (BN) rats by transplantation of Lewis (LEW) liver, bone marrow cell (BMC) and heart 
allografts under a brief course of tacrolimus. The degree of microchimerism at 60 and 110 days was estimated with 
semiquanitative immunocytochemical and peR techniques. Tolerance at 110 days was assessed in the different control 
groups by challenge transplantation of nai've LEW hearts. In parallel experimental groups, an attempt was made to 
eliminate micro chimerism from the BN recipients. The animals were submitted at 60 days to 9.5-Gy total body 
irradiation (TBI), reconstituted immediately with nai've BN BMC, and tested for donor specific nonreactivity by LEW 
heart transplantation at 110 days. 
Results. After the TBI-reconstitution at 60 days, microchimerism was undetectable in BMC recipients at 110 days, 
significantly reduced in heart recipients, and least affected in liver recipients. Except in liver recipients, abrogation of 
LEW -specific nonreactivity was demonstrated by rejection of the priming grafts, or by rejection of the challenge heart 
grafts, and by in vitro immune assay. 
Conclusions. It is difficult to eliminate microchimerism in organ recipients once the donor cells have settled into tissue 
niches. 
Keywords: Microchimerism, Tolerance, Passenger leukocytes, Liver transplantation, Bone marrow cells. 
(Transplantation 2006;81: 438-444) 
I t is generally accepted that the acute migration of multilin-
eage leukocytes from the organ graft into the host (1-6) has 
profound immunologic implications. However, the role, if 
any, of persistent small numbers of donor cells (micro-
chimerism) in the maintenance of organ alloengraftment has 
been controversial (7-13). An ideal way to assess the biologic 
significance of such microchimerism would be to study the 
consequences of eliminating the donor leukocytes from re-
cipients of stable transplanted organs. We report here an ef-
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fort to remove microchimerism in Brown Norway (BN) rat 
recipients of Lewis (LEW) heart, liver, or bone marrow cell 
(BMC) allografts. 
To generate controls, we used a previously standard-
ized model, in which a spectrum of microchimerism-associ-
ated donor specific nonreactivity (tolerance) is reproducibly 
induced under a short course of tacrolimus (14). In addition 
to histopathologic analysis of the primary graft, the extent of 
the tolerance is assessed in this model by transplantation of a 
challenge LEW heart at 110 days. In the present study, the 
highly reproducible microchimerism in such experiments 
and the associated donor-specific nonreactivity were com-
pared with the outcomes when the allograft-primed BN re-
cipients were subjected to total body irradiation (TBI, 9.5 Gy) 
after 60 days, and reconstituted immediately with an infusion 
of naive BN BMC. Even with this drastic procedure, it was not 
possible in organ recipients to completely eliminate the mi-
crochimerism. 
MATERIALS AND METHODS 
Animals 
LEW (RTll) donor and BN (RTl n) recipient rats 
weighing 150-250 g (Harlan Sprague Dawley, Indianapolis, 
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Indiana) were kept in a specific pathogen-free environment, 
fed a standard diet, and provided water ad libitum. The guide-
lines were observed of the Council on Animal Care at the 
University of Pittsburgh and the National Research Council's 
Guide for the humane Care and Use of Laboratory Animals. 
Organ/Cell Transplantation Procedures 
Orthotopic liver transplantation (OLTx) without ar-
terial reconstruction and heterotopic heart transplantation 
(HTx) into the abdomen were carried out as previously 
described (14). Rejection of heart and liver allografts was 
defined as the cessation of heartbeat and animal survival, 
respectively. 
BMC were obtained by flushing the tibias and femurs 
with RPMI 1640, supplemented with 25 mM HEPES buffer, 
2 mM L-glutamine, and 10 J.Lg/ml gentamicin (all from Life 
Technologies, Grand Island, NY). BMC (2.5XI08 cells/ani-
mal) with >95% viability were injected intravenously via the 
penile or jugular vein. 
Immunosuppression 
Tacrolimus (Fujisawa Pharmaceutical Co., Osaka, Ja-
pan) was given at a daily intramuscular dose of 1.0 mg/kg on 
days 0 to 6 after transplantation. A single supplemental injec-
tion of the same dose was given on days 13 and 20. 
Experimental Design 
Male or femaleBN rats received male LEW heart 
(Group 1, Fig. 1), liver (Group 2), or BMC (Group 3) grafts 
under a short course tacrolimus immunosuppression. In 
Groups 4-6, depletion of persisting donor passenger leuko-
nGURE 1. Experimental design in which all six groups 
of BN recipients were given LEW priming allografts under a 
short course of tacrolimus (TAC) immunosuppression and 
tested for donor-specific reactivity 110 days later by chal-
lenge LEW heart transplantation (bold arrows). No other 
treatment was given to the animals of groups 1-3. In Groups 
4-6. it was attempted to remove donor leukocyte micro-
chimerism by 9.5 Gy TBI and immediate reconstitution with 
5X 107 naive BN BMC (shaded arrows). Transplantations 
were of heterotopic hearts (HTx). orthotopic livers (OLTx). 
and infused bone marrow cells (BMC). 
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cytes was attempted at 60 days after primary transplants. BN 
recipients oHEW heart (Group 4), liver (Group 5) or BMC 
allografts (Group 6) were subjected to 9.5 Gy TBI (137Cs 
Gammacell 40), and infused on the same day with 5XI07 
female naIve BN unfractionated bone marrow cells for hema-
tolymphoid reconstitution. At 110 days after priming (50 
days after TBI and reconstitution), the recipients were chal-
lenged with naive LEW heart grafts. Animals were followed 
until the rejection of primary or challenge allografts or for 100 
days after challenge heart transplantation. 
Two sets of control animals were studied. In one 
group, naIve BN rats were irradiated with 9.5 Gy TBI, but not 
reconstituted with BMC. All died with a mean survival of 
12.2 days (n=9). Therefore, TBI with 9.5 Gy is considered to 
be lethal. A second group demonstrated that TBI -syngeneic 
BM transplantation procedure was succeeded by prompt re-
covery of vigorous host immune responsiveness. In these ex-
periments, naIve BN recipients were irradiated with 9.5 Gy 
TBI and reconstituted with syngeneic BN BMC. After 50-77 
days, LEW ~ BN heart transplantation was carried out. 
The LEW hearts were rejected with a median survival of 9 
days (n=3), the same as in naIve animals. The result sug-
gested that the reconstituted immune system did not have a 
major deficit. 
At autopsy, the liver or heart allografts, as well as the 
recipient liver, heart, kidney, spleen, thymus, skin (tongue), 
and cervical lymph nodes were sectioned and fixed in 10% 
neutral buffered formalin for routine histopathology. Other 
tissues were embedded in optimum cold temperature 
compound for immunohistochemical studies, and/or snap-
frozen in liquid nitrogen for DNA extraction. In addition, 
recipient cervical lymph nodes were taken for flow cytometry 
and mixed leukocyte reactions (MLR). 
Pathologic Studies 
The formalin-fixed heart and liver grafts were embed-
ded in paraffin, sectioned at 4 J.Lm and stained with hema-
toxylin and eosin. Histopathological changes in heart allo-
grafts were evaluated by the presence or absence of 
obliterative arteriopathy (OA) and endocardial, pericardial, 
interstitial and periarterial mononuclear inflammation 
with patchy interstitial fibrosis (15). In the liver allografts, 
particular attention was directed to the presence or absence 
of bile duct damage and/or loss, bile ductular prolifera-
tion, subendothelial mononuclear infiltration in the portal 
or central veins, and severity of portal tract inflammation 
(16). 
In Vitro Immunological Analyses 
Mixed Leukocyte Reaction 
Anti-donor reactivity of BN recipients was assayed 
with one-way mixed leukocyte reaction (MLR) as previously 
described (14). Triplicate cultures of responder cervical 
lymph node lymphocytes (1.75XIOs) and irradiated stim-
ulator cells (2000 rad, 3 XI 05) were incubated in a humidi-
fied atmosphere of 5% CO2 in air for 4 days at 37°C. One 
/LCi of 3H-thymidine was added to each well 16 hr before 
the termination of the culture. Cultures were harvested 
and 3H-thymidine uptake was determined by liquid scint-
illation. 
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Flow Cytometry 
Lineages oflymphocytes obtained from cervical lymph 
nodes were analyzed by two-color flow cytometry using PE 
or FITC-conjugated monoclonal antibodies (mAbs) OXS 
(CDSa), W3/25 (CD4), and OX39 (CD25, IL-2R) (Phar-
mingen, San Diego, CA or Serotec, Kidlington, Oxford, UK). 
Isotype-matched nonspecific antibodies were substituted for 
the primary reagents in the negative controls. The samples 
were fixed and analyzed on a Counter Elite ESP. 
Leukocyte Chimerism Determination 
Immunohistopathology 
Donor MHC class n+ cells were looked for in 4 p.,m 
tissue sections stained with a routine indirect avidin-biotin 
complex method using mAb L21-6 (mouse IgG1), that 
reacts with class II MHC antigens ofLEW but not BN (17). 
Isotype matched non-specific antibody was substituted in 
controls. 
Y -chromosome PCR 
In male ~ female transplant experiments, quantitation 
of male DNA in host tissues was performed by conventional 
PCR with Y -chromosome specific Southern hybridization 
and by SYBR Green real-time (quantitative) PCR. Genomic 
DNAs were prepared from recipient tissues using QIAamp 
kit (Qiagen Inc., Chatworth, CAl as described by the manu-
facturer, and the concentration of isolated DNA was mea-
sured by OD260/280 using Thermo Electron Spectroscopy 
(Thermo, Madison, WI). 
In conventional PCR method, PCR was performed 
with 1.5 p.,g genomic DNA in 50 p.,l of total reaction mix-
ture containing 1.25U Taq DNA polymerase and 1 p.,l each 
of 25 p.,M rat sex determining region-Y (Sry) specific oligo-
nucleotide primers (5'-GAGAGAGGCACAAGTTGGC-3' 
and 5'-GCCTCCTGGAAAAAGGGCC-3') as previously 
described (18). The PCR products were then fractionated 
in 1.5% agarose gels and transferred onto nylon membranes 
for Southern blotting and semiquantitation. Sry-specific 
probe was prepared by extraction and purification of 
PCR product of male LEW spleen DNA and multiprime-
labeled with alpha_32p dCTP. After hybridization with the 
p32-labeled probe, membranes were exposed to Storage Phos-
phor Screen (Molecular Dynanlics, Sunnyvale, CAl, and the 
radioactivity was measured by PhosphorImager (Molecular Dy-
namics) (18). 
SYBR Green real time PCR for rat Sry genes was per-
formed using oligonucleotide primers (5'-AAGTCAAGCG-
CCCCATGA-3' and 5'-TGAGCCAACTTGTGCCTCTCT-3'). 
For the internal control, rat GAPDH gene oligonucleotide 
primers (5'-ATGCTGGTGCTGAGTATGTCG-3' and 5'-
GTGGTGCAGGATGCATTGCTGA-3') were used. The reac-
tions were performed in duplicate by SYBR Green PCR mix 
(Applied Biosystems, Foster City, CAl using an ABI7000 Prism 
Sequence Detection System (Perkin Elmer, Foster City, CAl. 
The thermal cycler was configured as following: incubation 
(95°C, 10 min), up to 40 cycles of denaturation (95°C, 15 sec), 
and annealing and extension (60°C, 60 sec). 
In both PCR methods, the level of chimerism in each 
sample was calculated with a standard curve prepared by 
known concentrations of male DNA. As we previously re-
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ported (18), it was possible to detect the male DNA con-
centration -0.001 % using conventional PCR and Southern 
hybridization method. In the real-time PCR method, the de-
tection sensitivity was also -0.001%, similar to levels re-
ported in other human/mouse studies using real-time quan-
titative Y-chromosome-specific PCR methods (19-21). For 
each assay, standards and negative control without template 
were included. Donor DNA was considered as nondetectable 
when experimental samples showed below the value of con-
trol female samples. 
Statistical Analysis 
Results were reported as mean ± SD. Student t test 
was used for the analyses of flow cytometry and MLR results. 
P value less than 0.05 was considered significant. 
RESULTS 
TBI-Reconstitution Eliminated Microchimerism 
Confirming previous observations (14), sparse and het-
erogeneously distributed LEW MHC class n+ mononuclear 
leukocytes were found in the tissues ofBN recipients that had 
been primed 110 days earlier with all three kinds of allografts 
(data not shown). The rank order concentration of donor 
cells after the three kinds of priming was liver (highest) ~ 
BMC ~ heart. Also confirming previous studies (5, 15,22-
24), the organ allografts appeared to be privileged sanctuaries 
(i.e., the donor cells were more highly concentrated in the 
organ allografts; Fig. 2A) than in recipient tissues. Donor 
MHC class n+ cells persisting in the liver grafts were mostly 
dendritic cells located in the portal triad and some resident 
sinusoidal Kupffer cells with a frequency of 19.2± 15.0 cells/ 
high power field (HPF, X400) (5,23). 
TBI-reconstitution greatly reduced the number of 
MHC class n+ LEW cells detected with the L21-6 mAb, in-
cluding in the highly privileged site of the priming hepatic 
allograft (Fig. 2B). Although few LEW MCH class II faintly 
positive cells (0.31±0.70 cells/HPF, n=3) were found in the 
host tissues of the liver-primed and irradiated recipients at 
110 days, they could rarely be identified with certainty in 
the irradiated heart-primed recipients and were never seen in 
the BMC-primed recipients. 
These results with immunocytochemical staining were 
consistent with polymerase chain reaction studies in female 
BN recipients of male LEW allografts who were irradiated 
and reconstituted with naive female BN bone marrow 
(Fig. 2C and D). Probes for male DNA revealed unequivocal 
widely-distributed male DNA in all primed recipients before 
TBI-reconstitution (n=3 for each group). Liver-primed re-
cipients tended to have higher levels of donor male DNA than 
HTx- or BMC-primed recipients. After TBI-reconstitution, 
male DNA signals were essentially zero in BMC-primed re-
cipients. Trace quantities of male DNA were found in heart-
primed recipients (Fig. 2D and insert). The most male DNA 
was in liver recipients (Fig. 2D and insert). 
Leukocyte Lineage Composition Was Not Altered 
by TBI-Reconstitution 
The percentages of CD4+, CDS+ and CD4+CD25+ 
lymphocytes in naive BN rats were S4.0±7.9, 5.5±0.7, and 
6.4±0.4%, respectively. Sixty days after priming transplanta-
© 2006'Lippincott Williams & Wilkins 
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nGURE 2. Microchimerism after 110 days in female BN 
recipients primed with male LEW allografts before and af-
ter TBl reconstitution. (A) Transplanted LEW liver after 110 
days in non-irradiated BN recipients (see Group 2, Fig. 1). 
LEW MHC class II+ cells in the periportal area are stained 
brown by the 121-6 mAb (arrows, insert, upper). Note that 
biliary epithelial cells remain negative for L21-6 (insert, 
lower). Original magnification, X200 and X600. (B) Trans-
planted LEW liver after 110 days in irradiated and reconsti-
tuted BN recipients (see Group 5, Fig. 1). Most of the donor 
MHC class II+ cells are missing, but some remain (arrows, 
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tion, the CD4 + population was significantly reduced 
(P<O.O 1) to about the same extent in all three kinds of organ 
recipients: 35.5±7.3% (BMC recipients), 37.3±7.0% (liver 
recipients) and 34.4±4.4% (heart recipients). The percentage 
ofCD8+ and CD4+ /CD25+ cells that have been identified as 
potential imm uno regulatory candidates (12, 25) were no dif-
ferent after 60 days in three groups of animals than in naive 
animals. Interestingly, the leukocyte profile that evolved in 
the first 60 days (up to the time ofTBI-reconstitution) was 
essentially the same as that 50 days later (i.e., the time of 
challenge heart transplantation at 110 days). 
Mixed Leukocyte Reaction Studies Showed That 
TBI Reconstitution Caused a Change of Donor 
Specific Nonreactivity toward Reactivity 
Sixty days after priming transplantation, antidonor 
proliferation was markedly suppressed in liver and BMC re-
cipients (p= 0.03), but only moderately so in heart recipients 
(P=0.07; Fig. 3A). In the control animals of Groups 1-3, the 
donor specific suppression was still evident by 110 days but 
was significant only in the liver-primed recipients (Fig. 3B). 
TBI-reconstitution at 60 days completely eliminated the 
LEW-specific nonreactivity in the BMC- and heart-primed 
recipients, but not in the liver-primed recipients (Fig. 3C). 
TBI Reconstitution Frequently Caused Rejection 
of Priming Beart But Not Priming Liver 
Allografts 
As expected, all of the control LEW heart (Group 1) and 
liver grafts (Group 2) survived in non-irradiated BN recipi-
ents until transplantation of a challenge LEW heart at 110 
days, and for another 100 days until termination of the exper-
insert, upper). Faint staining of biliary epithelial cells (ar-
row heads, insert, lower) suggests the possibility of subtle 
biliary injury that was not detectable with conventional his-
topathology. Three animals in each group were analyzed 
and representative picture is shown. Original magnifica-
tion, X 200 and X 600. (C) Standardized amplification curve 
made with artificial mixtures of serial male DNA concentra-
tions. Artificial mixtures were made with serial male DNA 
concentrations (10 serial dilutions of 100, 20, 4, 0.8, 0.16, 
0.032, 0.0064, 0.00128, 0.000427, 0.000142% male DNA) 
and analyzed with SYBR green real-time PCR. Upper panel 
shows Sry-specific marker ilRn curves for the 10 samples. 
Regular positive amplification curves were observed with 
ilRn curve shift to the right as male DNA concentration de-
creased. 10we panel shows standardized amplification 
curve plotted from these results. Cycle threshold values 
linearly correlated with the log of male DNA concentration 
(R2=0.9200535). (D) Male DNA concentrations (microchi-
merism) before (60 days) and after (l10 days) TBI-reconsti-
tution in tissues of female recipients of male heart, liver, 
and BMC allografts (Groups 4-6 in Figure 1, n=3 in each 
with SYBR green real-time PCR). At 60 days before TBI-
reconstitution, all primed recipients with IEW heart, liver 
and BMC showed -0.1 % donor male DNA. After TBI-recon-
stitution, the male DNA found in liver recipients (-0.001 %) 
was present in smaller amounts in heart recipients, but was 
not identifiable in BMC recipients (insert). BM, bone mar-
row; LN, lymph nodes; Sp, spleen; Kid, kidney; Sk, skin; Ht, 
heart; Lv, liver. 
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FIGURE 3. One-way MLR of BN cells (from cervical 
nodes) to irradiated stimulator cells. (A) 60 days: before 
TBIIreconstitution. (B) 110 days: without TBl/reconstitution. 
(C) 110 days: after TBl/reconstitution at 60 days. All results 
are expressed as mean stimulation index ± SD n = 3 each 
group. *P<0.05 vs. normal BN response to LEW stimulator 
cells. HTx, heart transplantation; OLTx, orthotopic liver 
transplantation; BMTx, bone marrow cell transplantation. 
iments (Table 1). Although the priming heart allografts con-
tinued to beat, they all developed characteristic chronic rejec-
tion (CR): OA, patchy interstitial fibrosis, and mononuclear 
infiltration in interstitial and periarterial areas. However, the 
priming liver allografts were normal at 210 days, except for 
occasional bile duct proliferation and mild lymphocytic infil-
trates in the portal triad. 
TBI and reconstitution altered the outcome. Instead of 
the universal survival of the original hearts seen in Group I, 
9 of the 12 priming heart grafts of the irradiated and recon-
stituted Group 4 ceased to beat at 73-110 days (Table 1) and 
had histopathologic findings of acute and/or chronic rejec-
tion. The 3 exceptional priming hearts that survived until 110 
days continued to beat after challenge heart transplantation 
and had findings of severe CR at 210 days. 
In contrast, all comparably irradiated and reconstituted 
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liver recipients (Group 5) retained their priming liver grafts 
until challenge heart transplantation at 110 days and for the 
following 100 days (Table 1). With blinded analysis of con-
ventional histopathologic sections, the priming hepatic allo-
grafts at 210 days were indistinguishable from the priming 
livers in the non-irradiated Group 2. Of interest, there was 
up-regulation of MHC class II on biliary epithelial cells in 
liver tissues of Group 5 stained with the mAb L21-6, suggest-
ing subtle biliary injury caused by rejection (Fig. 2B). 
TBI Reconstitution Usually Abrogated the 
Protection Afforded Challenge Hearts by 
Priming Heart and Priming BMC, but not 
that Afforded by Priming Liver Allografts 
All 26 challenge hearts survived for 100 days after trans-
plantation to non -irradiated recipients who had been primed 
110 days earlier with heart (n=6), liver (n=lO), and BMC 
(n=lO) (Table 1). By day 210, the challenge hearts in the 
heart- (Group 1) and BMC-primed recipients (Group 3) had 
developed moderate to severe CR, while the hearts trans-
planted to liver-primed recipients (Group 2) were normal 
(Fig. 4) . 
In the three heart-primed and irradiated recipients of 
the original 12 whose primary grafts were still beating at 110 
days (Group 4, Table 1), the challenge hearts survived until 
day 210 and had developed severe CR (Fig. 4). All of the LEW 
hearts transplanted into liver-primed and irradiated recipi-
ents beat until 210 days (Group 5), and were CR-free (Fig. 4). 
The worst results with challenge heart transplantation 
were in 16 irradiated BN recipients who had been primed 
with LEW BMC (Group 6, Table O. Only 2 of the 16 LEW 
challenge hearts transplanted at 110 days beat until 210 days. 
Nine of the other 14 were acutely rejected in 6-8 days 
(7.2::!:::0.8 days), significantly earlier than the 9.0::!:::0.8 days of 
LEW hearts transplanted into naIve unmodified animals 
(P<O.OOOl). Five more challenge hearts were lost to rejection 
between 10-28 days. The wide range of heart graft survival 
was reflected in a spectrum of histopathologic findings: severe 
acute rejection, CR, or a mixture. 
DISCUSSION 
Ko et al. (7) attempted to eliminate donor leukocyte 
micro chimerism in a rat model in which heterotopically 
transplanted cardiac allografts remain free of chronic rejec-
tion (CR) for 200 days following a brief posttransplant course 
of cyclosporine. A dose of donor leukocyte-specific monoclo-
nal antibody (mAb) administered on the day of transplant 
during the acute spread of graft passenger leukocytes resulted 
in allograft CR. In contrast, a dose injected at 18 days had no 
detrimental effect. Although the latter observation has been 
interpreted as evidence ruling out micro chimerism as a factor 
in the perpetuation of organ alloengraftment, none of the 
animals infused with the mAb at 18 days had elimination of 
microchimerism (7). Thus, these experiments merely dem-
onstrated the difficulty of eradicating micro chimerism once 
it was established. 
Although higher doses of irradiation or the addition 
of other myeloablative drugs may eliminate established mi-
crochimerism after organ transplantation, our data further 
demonstrate the difficulty of completely removing donor leu-
© 2006 Lippincott Williams & Wilkins Kiyomoto et al. 443 
TABLE 1. Survival of primary allografts and challenge donor heart allografts 
Primary grafts Challenge heart grafts 
Primary TBII Survival Survival 
Group transplant reconstitutiona n (days) Median Rejection n (days) Median Rejection 
HTx None 6 > 21O x 6 210 Chronic 6 > 100x6 100 Chronic 
2 OLTx None 10 >21OXIO 210 None 10 > loox lO 100 None 
3 BMC None 10 N/A N/A NA 10 > 100XIO 100 Chronic 
4 HTx Yes 12 73,87,87,88, 91 Acute/chronic 3 > 100x3 100 Chronic 
88,89, 93 
1l0X2, 
> 21OX3 
5 OLTx Yes 7 >21OX7 210 None 7 >100X7 100 None 
6 BMC Yes 16 NA N/A NA 16 6,6,7,7,7, 8 Acute/chronic 
8,8,8,8, 
10,13, 
25,25,28 
>IOOX2 
Median survival of LEW hearts in naive BN recipients is 9.0 days. 
a On 60 days after primary transplantation, recipients were irradiated with 9.S-Gy total body irradiation (TBl) and then were reconstituted 5 X 107 na'ive BN 
bone marrow cells intravenously. 
kocyte microchimerism once it is established in recipient tis-
sues. It is noteworthy that the passenger leukocytes of organs 
were less vulnerable to the chimerism-depleting effects of 
TBI-reconstitution than infused BMC alone. The explana-
tion for this observation is speculative. We have suggested 
that the copresence of the transplanted organ facilitates the 
survival of its peripheralized passenger leukocytes by provid-
ing a syngeneic haven (22, 23). Similarly, Bingaman and 
Larsen et al. (26) have shown that transplantation of a syn-
geneic bone shell may aid the production ofhematolympho-
poietic chimerism. 
I t has been well-established that the migration of organ 
passenger leukocytes occurs by the same routes as those taken 
by infused BMC as well as by hematogenously spreading non-
cytopathic microorganisms (2-6). The leukocyte traffic is 
selective at first to host lymphoid organs (6) . After a few days 
nGURE 4. Histopathological findings of challenge heart allografts after 100 days (210 days after primary transplanta-
tion). The six panel numbers correspond to the six groups shown in Figure I and histological findings in Table I. H&E stain, 
original magnification X 100. 
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or weeks, however, donor cells that escape destruction by the 
immune response they have induced move on to nonlym-
phoid niches that are relatively inaccessible to cellular and 
humoral effector mechanisms (5, 18), or back to the graft 
itself (22-24). In these privileged nonlymphoid locations, the 
passenger leukocytes appear to have a survival advantage 
analogous to that of residual microorganisms following a sys-
temic infection (27,28). 
Despite the failure to completely eliminate microchi-
merism in our organ recipients, the study demonstrated that 
variable organ-induced partial tolerance was abrogated in 
rough proportion to the reduction of the microchimerism. 
The latter finding is compatible with the hypothesis that mi-
crochimerism is essential for maintenance of clonal exhaus-
tion-deletion that is induced by the maximal initial flood of 
passenger leukocytes during the first few weeks after trans-
plantation (27,28). In this paradigm, however, persistent do-
nor cells migrating from the protected sites to organized lym-
phoid collections may have the undesired opposite effect of 
sustaining or initiating protective immunity (29, 30). Ander-
son and Matzinger (13) have demonstrated in mice how ex-
perimental variables can determine whether microchimerism 
results in one or the other outcome. 
The observations in our experiments also could be 
accommodated in (or even used to bolster) competing im-
munologic hypotheses of alloengraftment. For example, it 
could be argued that the loss or reduction of tolerance follow-
ing irradiation-reconstitution was simply due to purging of 
engraftment-facilitating immunoregulatory cells (25) or in-
terdiction of other linked antigen-dependent or antigen-in-
dependent cytokine- or idiotypic antibody-dependent mech-
anisms (12). In addition, the phenomenon of homeostatic 
proliferation that includes resurgence of antidonor memory 
cells (31) could be invoked to explain the loss of tolerance. 
As discussed elsewhere (4), the resistance of the liver to 
anti tolerance measures is particularly noteworthy and may 
involve locally secreted growth factors or other unique fea-
tures of the hepatic microenvironment. Examination of these 
theories and alternative mechanisms was beyond the intent of 
our experiments which were designed to determine the diffi-
cultyandfeasibilityofcompletelyeradicatingtissuemicrochim-
erism. 
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